Wells Fargo Maintains Overweight on Doximity, Lowers Price Target to $32

Doximity, Inc. Class A

Doximity, Inc. Class A

DOCS

0.00

Wells Fargo analyst Stan Berenshteyn maintains Doximity (NYSE: DOCS) with a Overweight and lowers the price target from $45 to $32.